The SOD1G93A transgenic model, expressing a mutant form of Cu2+/Zn2+ human SOD1, mirrors several pathological features of ALS, including progressive motor neuron degeneration, muscle atrophy, and a reduced lifespan [46,47]. Here, SOD1 is linked to amyotrophic lateral sclerosis.